BIOPHARMA HOLDING ApS — Credit Rating and Financial Key Figures
CVR number: 35206086
Slotsmarken 12, 2970 Hørsholm
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 592.00 | 706.00 | 1 194.00 | 949.00 | 921.36 |
| Costs of management | - 664.00 | - 623.00 | - 815.00 | - 911.00 | - 937.32 |
| EBIT | -72.00 | 83.00 | 379.00 | 38.00 | -15.96 |
| Other financial income | 1 664.00 | 1 815.00 | 1 981.00 | 2 125.00 | 1 389.12 |
| Other financial expenses | -89.00 | -4 604.00 | - 197.00 | -22 739.00 | -5 078.73 |
| Net income from associates (fin.) | -8.00 | 14 722.00 | -31 885.00 | ||
| Pre-tax profit | 1 495.00 | 12 016.00 | -29 722.00 | -20 576.00 | -3 705.58 |
| Income taxes | -27.10 | ||||
| Net earnings | 1 495.00 | 12 016.00 | -29 722.00 | -20 576.00 | -3 732.68 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 66.00 | 40.00 | 18.00 | 1.00 | |
| Tangible assets total | 66.00 | 40.00 | 18.00 | 1.00 | |
| Holdings in group member companies | 89.00 | ||||
| Participating interests | 128 659.00 | 142 650.00 | 110 765.00 | ||
| Investments total | 128 907.00 | 142 813.00 | 110 940.00 | 182.00 | 202.89 |
| Non-curr. owed by particip. interest comp. | 21 844.00 | ||||
| Non-current other receivables | 23 968.00 | ||||
| Long term receivables total | 21 844.00 | 23 968.00 | |||
| Inventories total | |||||
| Current trade debtors | 287.00 | 349.00 | 511.00 | 196.00 | 225.48 |
| Prepayments and accrued income | 12.00 | 12.00 | |||
| Current other receivables | 20.00 | 26 131.00 | 27 158.00 | 2 620.84 | |
| Short term receivables total | 307.00 | 361.00 | 26 654.00 | 27 354.00 | 2 846.33 |
| Other current investments | 88 202.00 | 0.18 | |||
| Cash and bank deposits | 34.00 | 129.00 | 190.00 | 202.00 | 90.34 |
| Cash and cash equivalents | 34.00 | 129.00 | 190.00 | 88 404.00 | 90.52 |
| Balance sheet total (assets) | 151 158.00 | 167 311.00 | 137 802.00 | 115 941.00 | 3 139.74 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 73 429.46 | ||||
| Other reserves | 91 875.00 | 126 207.00 | 26 130.00 | 27 136.00 | -70 898.23 |
| Retained earnings | 52 812.00 | 19 974.00 | 132 069.00 | 101 339.00 | 4 042.55 |
| Profit of the financial year | 1 495.00 | 12 016.00 | -29 722.00 | -20 576.00 | -3 732.68 |
| Shareholders equity total | 146 262.00 | 158 277.00 | 128 557.00 | 107 979.00 | 2 921.10 |
| Non-current liabilities total | |||||
| Current trade creditors | 124.00 | 24.00 | 23.00 | 15.00 | 127.54 |
| Current owed to group member | 4 732.00 | 8 941.00 | 9 121.00 | 7 881.00 | |
| Short-term deferred tax liabilities | 27.10 | ||||
| Other non-interest bearing current liabilities | 40.00 | 69.00 | 101.00 | 66.00 | 64.00 |
| Current liabilities total | 4 896.00 | 9 034.00 | 9 245.00 | 7 962.00 | 218.64 |
| Balance sheet total (liabilities) | 151 158.00 | 167 311.00 | 137 802.00 | 115 941.00 | 3 139.74 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.